U S Concrete Inc (USCR) Fundamental Analysis & Valuation

NASDAQ:USCR

Current stock price

73.99
-0.01 (-0.01%)
At close:
74.04
+0.05 (+0.07%)
After Hours:

This USCR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. USCR Profitability Analysis

1.1 Basic Checks

  • USCR had positive earnings in the past year.

1.2 Ratios

Industry RankSector Rank
ROA -0.2%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 3.5%
PM (TTM) -0.23%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. USCR Health Analysis

2.1 Basic Checks

  • There is no outstanding debt for USCR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

  • Based on the Altman-Z score of 1.51, we must say that USCR is in the distress zone and has some risk of bankruptcy.
  • A Debt/Equity ratio of 1.97 is on the high side and indicates that USCR has dependencies on debt financing.
Industry RankSector Rank
Debt/Equity 1.97
Debt/FCF N/A
Altman-Z 1.51
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

  • USCR has a Current Ratio of 1.45. This is a normal value and indicates that USCR is financially healthy and should not expect problems in meeting its short term obligations.
  • USCR has a Quick Ratio of 1.11. This is a normal value and indicates that USCR is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.45
Quick Ratio 1.11

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. USCR Growth Analysis

3.1 Past

  • USCR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -75.70%.
  • USCR shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -13.67% yearly.
  • USCR shows a decrease in Revenue. In the last year, the revenue decreased by -7.91%.
  • USCR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.98% yearly.
EPS 1Y (TTM)-75.7%
EPS 3Y-10.83%
EPS 5Y-13.67%
EPS Q2Q%-275.51%
Revenue 1Y (TTM)-7.91%
Revenue growth 3Y0.74%
Revenue growth 5Y6.98%
Sales Q2Q%1.46%

3.2 Future

  • The Earnings Per Share is expected to grow by 22.40% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, USCR will show a small growth in Revenue. The Revenue will grow by 2.14% on average per year.
EPS Next Y20.4%
EPS Next 2Y22.52%
EPS Next 3Y28.3%
EPS Next 5Y22.4%
Revenue Next Year0.78%
Revenue Next 2Y3.38%
Revenue Next 3Y2.15%
Revenue Next 5Y2.14%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
USCR Yearly Revenue VS EstimatesUSCR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
USCR Yearly EPS VS EstimatesUSCR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

1

4. USCR Valuation Analysis

4.1 Price/Earnings Ratio

  • USCR is valuated quite expensively with a Price/Earnings ratio of 142.29.
  • The average S&P500 Price/Earnings ratio is at 26.91. USCR is valued rather expensively when compared to this.
  • Based on the Price/Forward Earnings ratio of 23.25, the valuation of USCR can be described as rather expensive.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 21.99, USCR is valued at the same level.
Industry RankSector Rank
PE 142.29
Fwd PE 23.25
USCR Price Earnings VS Forward Price EarningsUSCR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.62
USCR Per share dataUSCR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates USCR does not grow enough to justify the current Price/Earnings ratio.
  • USCR's earnings are expected to grow with 28.30% in the coming years. This may justify a more expensive valuation.
PEG (NY)6.97
PEG (5Y)N/A
EPS Next 2Y22.52%
EPS Next 3Y28.3%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. USCR Dividend Analysis

5.1 Amount

  • No dividends for USCR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

USCR Fundamentals: All Metrics, Ratios and Statistics

U S Concrete Inc

NASDAQ:USCR (8/25/2021, 8:08:07 PM)

After market: 74.04 +0.05 (+0.07%)

73.99

-0.01 (-0.01%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryConstruction Materials
Earnings (Last)N/A
Earnings (Next)02-28
Inst Owners0%
Inst Owner Change0%
Ins Owners12.18%
Ins Owner Change0%
Market Cap1.27B
Revenue(TTM)1.32B
Net Income(TTM)-3.10M
Analysts60
Price Target70.72 (-4.42%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 142.29
Fwd PE 23.25
P/S 0.96
P/FCF N/A
P/OCF N/A
P/B 3.34
P/tB N/A
EV/EBITDA 13.62
EPS(TTM)0.52
EY0.7%
EPS(NY)3.18
Fwd EY4.3%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS77.11
BVpS22.15
TBVpSN/A
PEG (NY)6.97
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -0.2%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 3.5%
PM (TTM) -0.23%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.87
Health
Industry RankSector Rank
Debt/Equity 1.97
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.45
Quick Ratio 1.11
Altman-Z 1.51
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-75.7%
EPS 3Y-10.83%
EPS 5Y-13.67%
EPS Q2Q%-275.51%
EPS Next Y20.4%
EPS Next 2Y22.52%
EPS Next 3Y28.3%
EPS Next 5Y22.4%
Revenue 1Y (TTM)-7.91%
Revenue growth 3Y0.74%
Revenue growth 5Y6.98%
Sales Q2Q%1.46%
Revenue Next Year0.78%
Revenue Next 2Y3.38%
Revenue Next 3Y2.15%
Revenue Next 5Y2.14%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

U S Concrete Inc / USCR Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for U S Concrete Inc?

ChartMill assigns a fundamental rating of 2 / 10 to USCR.


Can you provide the valuation status for U S Concrete Inc?

ChartMill assigns a valuation rating of 1 / 10 to U S Concrete Inc (USCR). This can be considered as Overvalued.


What is the profitability of USCR stock?

U S Concrete Inc (USCR) has a profitability rating of 1 / 10.


What is the valuation of U S Concrete Inc based on its PE and PB ratios?

The Price/Earnings (PE) ratio for U S Concrete Inc (USCR) is 142.29 and the Price/Book (PB) ratio is 3.34.


How financially healthy is U S Concrete Inc?

The financial health rating of U S Concrete Inc (USCR) is 2 / 10.